These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 7479904)

  • 1. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
    Gishizky ML; Cortez D; Pendergast AM
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10889-93. PubMed ID: 7479904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
    Cortez D; Kadlec L; Pendergast AM
    Mol Cell Biol; 1995 Oct; 15(10):5531-41. PubMed ID: 7565705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
    Puil L; Liu J; Gish G; Mbamalu G; Bowtell D; Pelicci PG; Arlinghaus R; Pawson T
    EMBO J; 1994 Feb; 13(4):764-73. PubMed ID: 8112292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes.
    Peng Z; Luo HW; Yuan Y; Shi J; Huang SF; Li CL; Cao WX; Huang ZG; Feng WL
    Oncol Rep; 2011 May; 25(5):1381-8. PubMed ID: 21369701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
    Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
    Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
    Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
    Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo.
    LaMontagne KR; Flint AJ; Franza BR; Pandergast AM; Tonks NK
    Mol Cell Biol; 1998 May; 18(5):2965-75. PubMed ID: 9566916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.
    Skorski T; Nieborowska-Skorska M; Szczylik C; Kanakaraj P; Perrotti D; Zon G; Gewirtz A; Perussia B; Calabretta B
    Cancer Res; 1995 Jun; 55(11):2275-8. PubMed ID: 7757976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells.
    Tari AM; Arlinghaus R; Lopez-Berestein G
    Biochem Biophys Res Commun; 1997 Jun; 235(2):383-8. PubMed ID: 9199202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.
    Afar DE; Han L; McLaughlin J; Wong S; Dhaka A; Parmar K; Rosenberg N; Witte ON; Colicelli J
    Immunity; 1997 Jun; 6(6):773-82. PubMed ID: 9208849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells.
    Harrison-Findik D; Susa M; Varticovski L
    Oncogene; 1995 Apr; 10(7):1385-91. PubMed ID: 7537361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase.
    Million RP; Van Etten RA
    Blood; 2000 Jul; 96(2):664-70. PubMed ID: 10887132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the ABL SH3 domain reactivates de-oligomerized BCR-ABL for growth factor independence.
    Maru Y; Witte ON; Shibuya M
    FEBS Lett; 1996 Feb; 379(3):244-6. PubMed ID: 8603698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcr phosphorylated on tyrosine 177 binds Grb2.
    Ma G; Lu D; Wu Y; Liu J; Arlinghaus RB
    Oncogene; 1997 May; 14(19):2367-72. PubMed ID: 9178913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.